[1]Patent:CN104761514,2016,B,.Locationinpatent:Paragraph0028-0030
[2]TetrahedronLetters,2001,vol.42,#33,p.5601-5603
[3]BioorganicandMedicinalChemistry,2012,vol.20,#7,p.2455-2478
[4]BioorganicandMedicinalChemistry,2013,vol.21,#17,p.5647-5647
[5]BihangtillSvenskaVet.-Akad.Handlingar,vol.27,p.II,No.1,S.4
[6]HelveticaChimicaActa,1929,vol.12,p.663
[7]Diss.<Zuerich1928>,S.30,
[8]JournalofMedicinalChemistry,1965,vol.8,p.691-694
[9]ChemicalCommunications,2014,vol.50,#49,p.6526-6529
[10]GreenChemistry,2017,vol.19,#3,p.809-815
[1]JournalofOrganicChemistry,2018,vol.83,#16,p.9088-9095
[2]Patent:CN104761514,2016,B,.Locationinpatent:Paragraph0023-0025
[3]Patent:JP2005/314398,2005,A,.Locationinpatent:Page/Pagecolumn25
[4]JustusLiebigsAnnalenderChemie,1875,vol.177,p.62
[5]MagneticResonanceinChemistry,1987,vol.25,p.189-193
[6]RussianJournalofOrganicChemistry,2001,vol.37,#1,p.87-92
[7]TetrahedronLetters,2005,vol.46,#31,p.5127-5130
[8]StructuralChemistry,2011,vol.22,#2,p.373-383
[9]BioorganicandMedicinalChemistry,2012,vol.20,#7,p.2455-2478
[10]BioorganicandMedicinalChemistry,2013,vol.21,#17,p.5647-5647
[11]EuropeanJournalofMedicinalChemistry,2016,vol.117,p.167-178
[12]Tetrahedron,2014,vol.70,#48,p.9224-9229
[1]Heterocycles,1994,vol.37,#3,p.1511-1520
[1]TetrahedronLetters,2005,vol.46,#31,p.5127-5130
[1]EuropeanJournalofMedicinalChemistry,2016,vol.117,p.167-178
[1]Patent:CN104761514,2016,B.Locationinpatent:Paragraph0028-0030
[2]ChemicalScience,2018,vol.9,p.8553-8560
[3]TetrahedronLetters,2001,vol.42,p.5601-5603
[4]BioorganicandMedicinalChemistry,2012,vol.20,p.2455-2478
[5]BioorganicandMedicinalChemistry,2013,vol.21,p.5647-5647
[6]Patent:WO2019/43139,2019,A1.Locationinpatent:Page/Pagecolumn51
[7],vol.27,p.II,No.1,S.4
[8]HelveticaChimicaActa,1929,vol.12,p.663
[9]JournalofMedicinalChemistry,1965,vol.8,p.691-694
[10]ChemicalCommunications,2014,vol.50,p.6526-6529
[11]GreenChemistry,2017,vol.19,p.809-815
[12]Patent:WO2019/217834,2019,A1.Locationinpatent:Page/Pagecolumn27
[1]JournalofOrganicChemistry,2018,vol.83,p.9088-9095
[2]Patent:CN104761514,2016,B.Locationinpatent:Paragraph0023-0025
[3]Patent:JP2005/314398,2005,A.Locationinpatent:Page/Pagecolumn25
[4]JustusLiebigsAnnalenderChemie,1875,vol.177,p.62
[5]MagneticResonanceinChemistry,1987,vol.25,p.189-193
[6]RussianJournalofOrganicChemistry,2001,vol.37,p.87-92
[7]TetrahedronLetters,2005,vol.46,p.5127-5130
[8]StructuralChemistry,2011,vol.22,p.373-383
[9]BioorganicandMedicinalChemistry,2012,vol.20,p.2455-2478
[10]BioorganicandMedicinalChemistry,2013,vol.21,p.5647-5647
[11]EuropeanJournalofMedicinalChemistry,2016,vol.117,p.167-178
[12]Tetrahedron,2014,vol.70,p.9224-9229
[13]JournalofComputer-AidedMolecularDesign,2019,vol.33,p.775-785
[14]Patent:WO2019/217834,2019,A1.Locationinpatent:Page/Pagecolumn27
[1]Heterocycles,1994,vol.37,p.1511-1520
[1]OrganicandBiomolecularChemistry,2019,vol.17,p.8522-8526
[2]Synlett,1999,p.1301-1303
[3]Patent:JP2005/314398,2005,A.Locationinpatent:Page/Pagecolumn25-26
[4]IlFarmaco,1997,vol.52,p.375-378
[5]Tetrahedron,2002,vol.58,p.7503-7518
[6]Tetrahedron,2000,vol.56,p.9633-9640
[7]Chemistry-AEuropeanJournal,2011,vol.17,p.13789-13794
[8]AngewandteChemie-InternationalEdition,2020,vol.59,p.704-710 Angew.Chem.,2020,vol.132,p.714-720,7
[1]EuropeanJournalofMedicinalChemistry,1998,vol.33,p.15-22
Title: N-(4-Methyl-benzo-yl)-2-nitro-benzene-sulfonamide.
Journal: Acta crystallographica. Section E, Structure reports online 20120301
Title: N-(3-Chloro-benzo-yl)-2-nitro-benzene-sulfonamide.
Journal: Acta crystallographica. Section E, Structure reports online 20120301
Title: N-(2-Chloro-benzo-yl)-2-nitro-benzene-sulfonamide.
Journal: Acta crystallographica. Section E, Structure reports online 20120201
Title: N-Benzoyl-2-nitro-benzene-sulfonamide.
Journal: Acta crystallographica. Section E, Structure reports online 20120201
Title: N-(3-Methyl-benzo-yl)-2-nitro-benzene-sulfonamide.
Journal: Acta crystallographica. Section E, Structure reports online 20120201
Title: ChemicalTagger: A tool for semantic text-mining in chemistry.
Journal: Journal of cheminformatics 20110101
Title: Total synthesis of (+)-vinblastine: control of the stereochemistry at C18'.
Journal: Chemical record (New York, N.Y.) 20100401
Title: Synthesis of a 6-aryloxymethyl-5-hydroxy-2,3,4,5-tetrahydro-[1H]-2-benzazepin-4-one: a muscarinic (M3) antagonist.
Journal: Organic & biomolecular chemistry 20080621
Title: Novel use of chemical shift in NMR as molecular descriptor: a first report on modeling carbonic anhydrase inhibitory activity and related parameters.
Journal: Bioorganic & medicinal chemistry letters 20050215
Title: Topological modeling of lipophilicity, diuretic activity, and carbonic inhibition activity of benzene sulfonamides: a molecular connectivity approach.
Journal: Bioorganic & medicinal chemistry letters 20041115
Title: DNA display III. Solid-phase organic synthesis on unprotected DNA.
Journal: PLoS biology 20040701
Title: An efficient and versatile synthesis of acylpolyamine spider toxins.
Journal: Bioorganic & medicinal chemistry letters 20020211
Title: A rigid linker-scaffold for solid-phase synthesis of dimeric pharmacophores.
Journal: Journal of combinatorial chemistry 20010101